Researchers developed a dual-modality imaging system that combines high-resolution structural and chemical analysis with AI to improve skin cancer diagnosis.
Key Details
- 1The system merges line-field confocal optical coherence tomography (LC-OCT) with confocal Raman microspectroscopy.
- 2Over 330 nonmelanoma skin cancer samples were examined in a year-long clinical study.
- 3AI models trained on chemical spectra achieved classification accuracy of 0.95 for basal cell carcinoma and 0.92 for both basal and squamous cell carcinoma.
- 4The approach allows targeted, noninvasive analysis of suspicious skin structures at cellular and molecular levels.
Why It Matters
This innovation promises less invasive, more accurate skin cancer diagnosis by combining structural and biochemical imaging with AI classification, potentially reducing reliance on biopsies and improving patient outcomes.
Source
EurekAlert
Related News
•EurekAlert
Study Warns: AI Alone Is Not Enough in Critical Healthcare Decisions
Evaluating both AI algorithms and human users is key for safe adoption in high-stakes healthcare settings, according to an Ohio State study.
•EurekAlert
AI Dramatically Improves Prediction of Delivery Timing from Ultrasound Images
Ultrasound AI's study validates advanced AI for predicting delivery timing using standard ultrasound images.
•EurekAlert
AI Voice Analysis Shows Promise for Early Laryngeal Cancer Detection
Researchers demonstrated AI could detect early laryngeal cancer from voice recordings, distinguishing it from benign conditions.